LiveRamp's AI Push and Q3 Results: Steady Execution, But Growth Deceleration Lingers

What happened

LiveRamp announced new Agentic AI integrations, launching SemantlQ and Newton Research agents to enhance real-time campaign analysis and audience building in privacy-centric environments. A strategic partnership with Scowtt aims to deliver predictive AI signals to platforms like Meta and Google, reportedly driving client ROAS above 40% and reinforcing its competitive moat. Q3 financial results show $212M revenue, up 9% year-over-year, with $0.76 non-GAAP EPS, a 29% operating margin, and ARR of $527M, supporting a stable 9% growth outlook and a Rule of 40 target by 2028. This aligns with the DeepValue report's base scenario of 8–10% revenue growth, but the ARR figure, while slightly higher than prior $516M, still reflects deceleration from historical levels and subscription net retention stuck near 102%. Despite AI-driven optimism, the fundamental challenge remains accelerating bookings and net retention to unlock valuation upside beyond the current cautious market sentiment.

Implication

The new AI agents and partnership may enhance LiveRamp's platform stickiness and client ROI, potentially supporting higher usage and mitigating competitive threats from hyperscalers. However, Q3's 9% revenue growth and ARR trajectory mirror the DeepValue report's concerns about decelerating demand, with subscription net retention at 102% indicating limited upsell momentum. Improved operating margins to 29% are encouraging, but mix-driven gross margin compression and regulatory risks continue to cap upside without a clear re-acceleration in bookings. The Rule of 40 target by 2028 suggests a balanced path, but execution risks persist, especially as market sentiment remains stuck in 'Hold' territory with consensus expecting only high-single-digit growth. Thus, the implication is unchanged: patience is warranted, with investors needing to monitor upcoming quarters for evidence of ARR growth reaching ≥10% or a pullback to the $20 attractive entry point before considering a more aggressive stance.

Thesis delta

The news does not shift the core investment thesis; ARR growth remains in line with prior cautious expectations, and while AI initiatives could support future demand, they have yet to materially improve key metrics like net retention. Margins have strengthened, but without evidence of accelerated bookings or ARR re-acceleration, the thesis remains a 'WAIT' for better entry points or clearer growth inflections. Investors should still look for ARR growth to reach ≥10% or a price drop to ~$20 to reassess the risk-reward profile positively.